Introduction
The value of perfusion scintigraphy in the detection of pulmonary embolism (PE) was demonstrated as early as 1964 by Wagner et al. PE causes perfusion defects that conform to the anatomical distribution of the pulmonary vascular bed. Perfusion defects in acute PE are therefore of sub-segmental, segmental or lobar character. Ventilation is normally preserved in these areas and the observed wedge shaped mismatch between ventilation and perfusion is typical for PE. Planar ventilation/perfusion scintigraphy (V/P scan) was until the 1990s the method of choice for studying patients with suspected PE. However, the large Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED I), showed a high number of non-diagnostic examinations (65%) with V/P scan and the probabilistic interpretation criteria were confusing to the clinicians (Gray et al., 1993; The PIOPED Investigators, 1990) . Planar imaging has become obsolete, particularly when the issue is identification and quantification of focal or regional aberration of organ function. The advantage of three dimensional tomography over planar imaging for PE detection had already been shown in 1983 in a study on dogs (Osborne et al., 1983) . Furthermore, Magnussen et al. (1999) used a computerized model of PE to highlight the advantage of SPECT over planar imaging in the assessment of the size and location of perfusion defects. Using a dual head camera, Palmer et al. (2001) , developed a fast and efficient method for ventilation/perfusion tomography (V/P SPECT ) for clinical practice with total acquisition time of only 20 minutes. Moreover, they developed an algorithm to calculate the quotient between ventilation and perfusion and to present it as V/P quotient images. This facilitated PE diagnosis and the quantification of PE extension, which led to the use of the term quantitative V/P SPECT. Using a porcine model, Bajc et al. validated V/P SPECT for diagnosis of PE and confirmed the superior value of tomography over planar imaging with excellent interobserver agreement of defects down to the sub-segmental level (Bajc et al., 2002b) . The objective of this chapter is to acquaint readers with the latest methodological approach of V/P SPECT in the diagnosis of PE, in accordance with the new guidelines of the European Association of Nuclear Medicine (Bajc et al., 2009a, b) . In this chapter we also discuss the value of V/P SPECT in the follow up after acute PE and in the diagnosis of other cardiopulmonary diseases.
Efficient and effective diagnostics for PE and other diseases should meet the following basic requirements:  Fast procedure and prompt availability of results  Feasibility for all patients  High diagnostic accuracy and few non-diagnostic reports  Low radiation dose  Utility for selection of treatment strategy  Suitability for follow up and research 
Ventilation and perfusion imaging
In healthy patients, regional ventilation and perfusion match each other to optimize gas exchange (Fig 1) . In diseased patients, changes in distribution of ventilation or perfusion or both are common. Vascular occlusive diseases, like PE, cause perfusion defects in conformity with pulmonary circulation while ventilation stays intact in these areas. This disconcordant ventilation/perfusion pattern, so called mismatch, provides the basis for PE diagnosis. Ventilation might be disturbed in acute PE due to bronchial constriction (Giuntini, 2001) but perfusion defects are usually observable in other areas (Fig 2a) . Ventilation commonly shows disturbances in lung diseases like pneumonia, tumours and obstructive diseases. Such perfusion patterns are essential to recognize as they provide additional specificity and significance to observed conditions.
Ventilation
For the ventilation study, gases may be used as they are distributed strictly according to regional ventilation. The gas that is used for V/P SPECT is metastable 81-krypton (81mKr). Its short half life, 13 s, implies that it disappears from the alveoli by decay at a much faster rate than by exhalation. Therefore, after a few minutes of breathing the test gas, the alveolar . The V/P mismatch is clearly delineated on V/P quotient images which improves visualization. Reduced ventilation is observed in posterior parts of the lung, where perfusion is preserved (blue arrows). B) Normalization of ventilation (blue arrows and perfusion is seen already after three days.
concentration will reflect alveolar ventilation. Ventilation is performed during continuous breathing of this gas. 81mKr has higher gamma energy than 99m-Technetium (99mTc) (191 compared to 140 keV) allowing simultaneous imaging of ventilation and perfusion. 81mKr is diluted from a rubidium generator that has a half life of 4.6 h. Its availability is limited and it is too expensive for general use. Routinely in clinical practice, inhalation of a radio-aerosol is used for ventilation scintigraphy. Aerosol particles are liquid or solid. The size of the particles is of critical importance. Particles larger than 2 μm are deposited in large airways. Smaller particles are deposited by sedimentation and diffusion in small airways and alveoli. Particles smaller than 1 μm, are mainly deposited in alveoli by diffusion. Aerosol deposition is modified by flow pattern. High flow rates at forced breathing patterns and turbulent flow enhances particle deposition in airways and increases the likelihood of hot spots formation on ventilation images, particularly in Chronic Obstructive Pulmonary Disease (COPD). Diethylenetriaminepentaacetic acid labeled with technetium, 99mTc-DTPA, is the most common agent used for ventilation scintigraphy. It is soluble in water and the size of the molecule is 492 Dalton. The average size of particles after nebulization is at best 1.3 to 1.8 μm. Due to the water solubility, particle size tends to increase during inhalation and to agglutinate in cases of bronchial obstruction where there are turbulent flows; this leads to the creation of hot spots. Because of the water solubility, 99mTc-DTPA particles also diffuse through the alveolo-capillary membrane to the blood. In a healthy patient, clearance of 99mTc-DTPA occurs with a half life of about 70 minutes. Increased clearance, leading to a shorter half life is observed where there is alveolar inflammation for any reason, such as alveolitis of an allergic or toxic nature and even in smokers. Clearance of 99mTc-DTPA can for diagnostic purposes be measured at a routinely performed V/P SPECT.
Technegas is a newer solid aerosol with extremely small carbon particles, 0.005-0.2 μm, labeled with 99mTc which are generated in a high temperature furnace. The small particle size implies that they are distributed in the lungs almost like a gas and are deposited in alveoli by diffusion (James et al., 1992) . Technegas provides images which are equivalent to those with 81mKr. Technegas significantly reduces problems of central airway deposition and peripheral hotspots. Patients routinely admitted for V/P SPECT and a group of patients with known COPD were recently studied with both 99mTc-DTPA and Technegas showing superiority of the latter (Jögi et al., 2010) . Unevenness of radiotracer deposition and degree of central deposition were significantly reduced with Technegas, particularly in the obstructive patients (Fig 3) . In some patients, mismatched perfusion defects were only identified using Technegas because the significant peripheral unevenness of 99mTc-DTPA obscured mismatch. PE might have been overlooked in COPD patients using 99mTc-DTPA. In a few patients, 99mTc-DTPA yielded images of very poor quality. Technegas is therefore recommended as the superior radio-aerosol, particularly in patients with obstructive lung disease. A further advantage of Technegas is that relatively few breaths are sufficient to achieve an adequate amount of activity in the lungs. 
Perfusion
Perfusion scintigraphy involves an intravenous injection of radio-labeled macroaggregates of albumin (MAA), sized 15-100 μm, which cause microembolization of pulmonary capillaries and pre-capillary arterioles in amounts reflecting regional perfusion. At least 60 000 particles are required to obtain a representative activity distribution (Heck & Duley, 1974) . Routinely, about 400 000 particles are injected. As there are over 280 billion pulmonary capillaries and 300 million pre-capillary arterioles, only a very small fraction of the pulmonary bed will be obstructed. A preparation of 100 000-200 000 particles is recommended for patients with known pulmonary hypertension or after a single lung transplant. Degradation of MAA results in its elimination from the lung within a few hours.
Acquisition
To perform V/P SPECT takes only one hour from referral to report (Bajc et al., 2004; Palmer et al., 2001) . The ventilation study starts with inhalation of 25-30 megabecquerel (MBq) Technegas, usually 2-3 breaths. Immediately after ventilation SPECT, a dose of 100-120 MBq 99mTc-MAA is given intravenously for perfusion imaging.
During the examination, the supine patient carefully maintains the position between ventilation and perfusion acquisitions. Immobilization for only 20 minutes is well tolerated by nearly all patients. Examination in supine position is comfortable even for critically ill patients. It is also more convenient for the staff. It is noteworthy that V/P SPECT can be performed in all patients, since there is no contraindication related to age, radiation, contrast media or co-morbidity.
Reconstruction and calculation of V/P quotient images
Iterative OSEM is essential for SPECT reconstruction. Ventilation activity is subtracted from perfusion images. A valuable parameter in clinical SPECT is the Ventilation/Perfusion quotient, V/P quotient (Bajc et al., 2004; Palmer et al., 2001) . V/P quotient is calculated after normalization of ventilation counts to perfusion counts. Hot spot removal is important, especially when 99mTc-DTPA is used.
Presentation of V/P SPECT
V/P SPECT images are usually presented in frontal, sagittal and transversal projections, available in any modern system. The slices must be accurately aligned so that ventilation and perfusion slices match each other for correct comparison. Therefore, it is crucial to achieve this acquisition in one session with maintained body position. This is also a prerequisite for the calculation of V/P quotient images, which greatly facilitates identification of ventilation/perfusion mismatches typical of PE as well as other patterns characteristic of other pulmonary diseases. Volume rendered images, such as "Maximum Intensity Projection" are available with almost all SPECT systems, allowing rotating 3D views. This function is another valuable option, particularly for quantification and follow-up of PE patients.
Interpretation
According to the new European guidelines, the holistic interpretation of lung SPECT is recommended (Bajc et al., 2009b) . The clinician can only benefit from reports, which clearly express the presence or absence of PE. This goal was not achieved with previous probabilistic reporting methods according to PIOPED or modified PIOPED. Large V/P SPECT studies show that this is achievable if all patterns are considered, where these combine ventilation and perfusion. Conclusive reports were given in 97 to 99 % of studies. Holistic interpretation of V/P SPECT should be based upon: a) Clinical pre-test probability and b) the application of criteria for interpreting V/P patterns to distinguish between patterns indicative of PE and other diseases.
Criteria for acute PE according the european guidelines
In accordance with the guidelines of the European Association of Nuclear Medicine (Bajc et al., 2009a, b) , PE is reported if there is:  V/P mismatch of at least one segment or two sub-segments that conforms to the pulmonary vascular anatomy. No PE is reported if there is:  normal perfusion pattern conforming to the anatomic boundaries of the lungs,  matched or reversed mismatch V/P defects of any size, shape or number in the absence of mismatch  mismatch that does not have a lobar, segmental or sub-segmental pattern Non-diagnostic for PE is reported if there are:  Multiple V/P abnormalities not typical of specific diseases. The fundamental point is that lobar, segmental or sub-segmental V/P mismatch serves as the basis for confirming a diagnosis of PE among patients with suspected PE. Howarth et al. state that: "at least 0.5 of a segment of ventilation/perfusion mismatch is considered diagnostic of PE" (Howarth et al., 2006) . This simplified criterion gave the highest combined sensitivity and specificity, observer reproducibility and fewest indeterminate results. In PE, a mismatch has its base along the pleura and conforms to known sub-segmental and segmental vascular anatomy (Miniati et al., 1996) . Applying these principles of interpretation, recent V/P SPECT studies of more than 3000 cases showed a negative predictive value of 97-99 %, a sensitivity of 96-99%, and a specificity of 91-98% for PE diagnosis (Bajc et al., 2008; Leblanc et al., 2007; Lemb & Pohlabeln, 2001; Miniati et al., 1996; Reinartz et al., 2004) . The rate of non-diagnostic findings was 1-3%. V/P SPECT yields ventilation and perfusion images in exactly the same projections, facilitating recognition of mismatch. This is of particular importance in the middle lobe and lingula where mismatch may be overlooked if the lung is not accurately delineated by its ventilation images (Meignan, 2002) . (Olsson et al., 2006) . Moreover, areas with ventilation abnormalities were recognized allowing estimation of the degree of total lung malfunction. A segmental reduction or a subsegmental total deficiency of function is attributed 1 point, a segmental total deficiency, 2 points. Each lung comprises according to our charts 9 segments, representing 18 points. Mismatch defects are expressed as mismatch points, which after division by 36 give the fraction of the lung that is embolised. Regions with ventilation or perfusion defects are totalled in order to estimate the reduction in overall lung function. The study showed that patients with up to 40 % PE could be safely treated at home if ventilation abnormalities engaged less than 20 % of the lung. Since 2004, the Skåne University Hospital, Lund, has successfully treated more than 2000 patients with PE and about 60 % of these patients were treated at home.
Diagnosis of pulmonary embolism
In PE, an embolus blocks the blood flow, causing a perfusion defect, while ventilation remains normal because there is no corresponding blockage in the airway. To characterize the pattern of perfusion defects is crucial. Perfusion defects due to blockage of a pulmonary artery should reflect the branching of pulmonary circulation and its classical segmental anatomy. A segmental defect is wedge shaped with its base on the pleura. On V/P SPECT images, it is relatively easy to identify segmental and sub-segmental patterns of perfusion defects. Figure 4a shows multiple perfusion defects in acute stage in a female patient with chest pains, who had fainted outside the hospital. Applying quantification on V/P SPECT images, extension of PE was estimated to be ca 60%. The patient was treated first with heparin for a week. However, Follow up showed limited regression (Fig 4b) . As brain hemorrhage was excluded, thrombolysis was administered. The following day perfusion was normalized (Fig 4c) . Figure 2 shows sagittal slices of right lung of a patient studied for acute breathlessness. A segmental perfusion defect was well delineated, in perfusion and V/Pquotient images (Fig 2a) . Moreover, it was possible to see broncho-constriction in the posterior part of the lung (blue arrow). The extension of perfusion defect was estimated at 10% and ventilation defect 25%. Three days later nearly complete resolution of the embolus was observed, as well as normalization of the ventilation (Fig 2b) . In planar images, the identification of a solitary segmental perfusion defect within middle lobe and lingula is often impossible or, at best, difficult. With tomographic images these changes are well delineated. It is important to be aware that mismatch findings not having segmental character do not usually represent PE. Non segmental mismatch means that perfusion defects do not conform to segmental anatomy and are caused by other diseases. This is observed in patients with heart failure (Jögi et al., 2008) , pneumonia, mediastinal adenopathy, post radiation therapy etc. Total absence of perfusion in one lung without any other region of mismatch is often caused by pathology other than PE, such as a central tumour or abscess.
Follow up
Follow up is a frequently overlooked aspect of diagnostic strategies although it is essential both for clinical and scientific reasons. The follow up is necessary to assess the effect of treatment, especially to see the effect of anticoagulant therapy (Fig 4b) and in these cases to be able to adjust therapy or, if necessary, continue with thrombolysis (Fig 4c) .
Moreover follow up is important 
To assess the need for prolonged oral anticoagulation beyond 6 months, where there are extensive remnants of PE. 
To allow differentiation between new and old PE, where a recurrence of PE is suspected. 
To explain physical incapacity after PE in case of permanently impaired lung function. 
To evaluate and compare drugs and treatment strategies. 
To identify patients with remaining perfusion defects after treatment as these could be particularly susceptible to developing pulmonary hypertension For follow up, V/P SPECT is the only suitable method for the following reasons:  Detection of all emboli requires that the whole lung is examined with a sensitive method. 
The cumulative radiation dose is a central issue when the indication for PE is relative  V/P SPECT is the only method which enables functional impairment to be determined due to increased dead space from non-perfused lung units and increased pulmonary vascular resistance due to a reduced vascular bed. To be able to study the efficacy of treatment, in individual patients the same method should be used both for diagnosis and follow up. This is a further strong argument in favour of V/P SPECT as the primary diagnostic method for PE. 
Chronic pulmonary embolism
Chronic PE is a progressive disease that develops in about 5 % of patients, even after treatment (Begic et al., 2011; Pengo et al., 2004) , after an acute episode of PE . However, it often has an insidious onset. It might lead to pulmonary hypertension, right heart failure and arrhythmia, which are frequent causes of death. The value of ventilation/perfusion scintigraphy is well established. It has recently been confirmed in a head to head comparison between MDCT and planar scintigraphy with pulmonary angiography as reference. Among patients with pulmonary hypertension, scintigraphy had a sensitivity of 96-97% and specificity of 90 %, while MDCT had a sensitivity of 51% (Tunariu et al., 2007) . The conclusion was that ventilation/perfusion scintigraphy "has a higher sensitivity than MDCT as well as very good specificity in detecting chronic pulmonary thromboembolic disease as a potentially curable cause of pulmonary hypertension". Scintigraphic features of chronic PE vary. Figure 5 illustrates a case of multiple perfusion defects which are similar to acute PE. MDCT was normal. In some patients mismatch without clear segmental or sub-segmental pattern is observed. Peripheral zones of the lung lack perfusion. The centre of the lung is hyperperfused. The lung appears significantly smaller on perfusion images compared to ventilation and the V/P quotient images show mismatch along the lung periphery ( Fig 6) . In recent guidelines for the diagnosis and treatment of pulmonary hypertension it is stated that "ventilation/perfusion scan remains the screening method of choice for chronic pulmonary hypertension" (Galie et al., 2009) . It was also pointed out that pulmonary venoocclusive disease is a rare but important differential diagnosis. 
Sensitivity and specificity of V/P SPECT and other methodological considerations
In a clinical study, 53 % more mismatch points were identified with V/P SPECT compared to planar technique (Bajc et al., 2004) . Similar results have been found by others (Gutte et al., 2010; Reinartz et al., 2001) . SPECT eliminates superimposed structures, clarifying segmental and sub-segmental nature of perfusion defects caused by PE. The value of V/P SPECT is further confirmed in clinical studies (Bajc et al., 2008; Gutte et al., 2009; Leblanc et al., 2007; Lemb & Pohlabeln, 2001) . V/P SPECT is today the recommended method for clinical diagnosis, follow up and research (Bajc et al., 2009b) . Powell reported that sensitivity and specificity of CT for central PE are about 90% (Powell & Muller, 2003) . Perrier et al. found in a broad clinical material that CT had a sensitivity of 70% for PE and a specificity of 91 % (Perrier et al., 2001) . They concluded: "clinical CT should not be used alone for suspected PE but could replace angiography in combined strategies that include ultrasonography and lung scanning". Likewise, van Strijen et al. found in a multicentre prospective study that sensitivity of CT was 69% while specificity was 84% and "concluded that the overall sensitivity of spiral CT is too low to endorse its use as the sole test to exclude PE" and that "this holds true even if one limits the discussion to patients with larger PE in segmental or larger pulmonary artery branches" (Van Strijen et al., 2005) . Our experience supports this view. Also, CT as a second procedure following scintigraphy has limited value (van Strijen et al., 2003) . Multislice CT seems to improve resolution but sensitivity for small PE appears not to be improved (Stein et al., 2006) . A problem associated with limited sensitivity of CT and incomplete coverage of the total lung is that the degree of embolism and lung function deficiency cannot be quantified. Quantification is important for treatment selection. In spite of excellent diagnostic qualities of V/P SPECT and documented low sensitivity of CT, the latter method is often recommended. A high number of non-diagnostic scintigraphies were reported in the PIOPED study (65%) (1990) . This is still used as an argument against lung scintigraphy. In PIOPED, scintigraphy was performed with inferior technique and inflexible sub-optimal interpretation criteria. Even with planar scintigraphy, a reduction in the number of non-diagnostic reports to 10% can be achieved with adequate acquisition and a holistic interpretation strategy (Bajc et al., 2002a) . With V/P SPECT, this number is further reduced to between 1 and 4%, as found in several studies (Bajc et al., 2008; Leblanc et al., 2007; Lemb & Pohlabeln, 2001) . Some practitioners hold that sub-segmental emboli are of little importance for otherwise healthy people and may be left untreated and, as a consequence, are prepared to accept less sensitive methods for PE diagnosis. However, small emboli are important because they 1) may be a first and only sign of silent deep venous thrombosis, 2) may precede larger emboli 3) if not diagnosed and/or untreated, further episodes may lead to chronic PE and pulmonary hypertension (Fig. 6) . 4) form a threat to patients with limited cardio-pulmonary reserve, 5) are clinically essential for quantification, which is necessary to scientifically establish appropriate treatment protocols. Thus, each embolus is relevant, irrespective of size. Sub-segmental emboli should not be left untreated without further scientific evidence.
Selection of therapeutic strategy
Management of PE was previously confined to in-hospital therapy, using anticoagulation, heparin injections followed by oral anticoagulants for extended periods of time. About 20 % to 55 % of patients with deep venous thrombosis have concomitant PE, which is usually not diagnosed because symptoms of PE are absent. Outpatient treatment of patients with deep venous thrombosis, which is perceived as a safe routine, implies that many patients with PE are treated at home. Home treatment of patients with diagnosed PE has been suggested (Kovacs et al., 2000) but in order to determine the appropriateness of the treatment on an individual basis, the extension of PE obviously need to be estimated. Whilst patients with limited extension of PE may be treated at home, intermediate cases and patients with co-morbidity may need in-hospital treatment. Those with very extensive PE may require thrombolysis, necessitating inpatient treatment. Obviously, quantification requires studies of the whole lung with methods allowing identification of large and small emboli. V/P SPECT is the ideal method for this purpose as segmental and sub-segmental emboli can be both detected with a high degree of sensitivity www.intechopen.com and quantified in terms of mismatch points. In a prospective study Olsson et al. studied 102 out-patients with a moderate degree of PE (up to 40%) (Olsson et al., 2006) . After only 5 days, embolism diminished by 44 % on average. There was no tromboembolic mortality in the trial. Later follow up indicated that PE had not recurred in patients showing resolution after 5 days. Since 2004, more than 1000 patients, of Skåne University Hospital, Lund, with up to 50% extension of PE have been treated as out-patients. After this positive experience, out-patient treatment is now perceived as a safe routine in patients who have been selected on the basis of V/P SPECT and relevant clinical information.
Additional findings
PE is a condition known for its non-specific symptoms. Medical imaging, such as V/P SPECT, is therefore necessary to confirm or exclude the diagnosis among patients with suspected PE. The majority of patients that are examined with V/P SPECT, due to the initial assumption of PE, will not have PE. It is therefore important that any alternative diagnoses, which could explain the patients' symptoms, are identified and provided to the referring physician. Possible alternative diagnoses include pneumonia, heart failure, pleural fluid, malignancy and chronic obstructive pulmonary disease (COPD) (Richman et al., 2004) . Another important aspect is that these conditions sometimes coexist and that they also elevate the risk of PE (Elliott et al., 2000) . V/P SPECT can be employed to identify other diagnoses than PE.
Chronic obstructive pulmonary disease
COPD is a major cause of both morbidity and mortality globally (Mannino et al., 2006) . It is one of the few diseases that continues to rise in numbers in many countries. COPD is an inflammatory disease characterized by airflow limitation that is not fully reversible (Celli & MacNee, 2004) . The airflow limitation is caused by a combination of airway obstruction and parenchymal destruction (emphysema). The pulmonary changes in COPD lead to inhomogeneous regional ventilation. V/P SPECT is sufficiently sensitive as a method to identify the functional changes in COPD. In comparison with DTPA aerosols, Technegas penetrates the lung periphery better (Jögi et al., 2010) , which is especially important in COPD (exemplified in Fig 3) . Technegas ventilation imaging has been shown to visualise the early changes of COPD before they can be observed with high resolution CT (HRCT) (Yokoe et al., 2006) . As COPD initially affects the airways, the ventilation defects are commonly more prominent than those of perfusion. Perfusion within the lungs also becomes abnormal as the lungs attempt to adapt the regional blood flow to ventilation to preserve an efficient gas exchange. Often this adaptation is incomplete and perfused but non-ventilated areas (low V/P ratio) occur, i.e. reverse mismatch (Gottschalk et al., 1993) . With progressive disease, concurrent destruction of airways and blood vessels takes place and matched defects with absence of both ventilation and perfusion are seen. Vascular remodeling in COPD may lead to regions with elevated V/P ratios. Garg et al. (1983) found that the degree of abnormality on aerosol ventilation images significantly correlated to pulmonary function tests. In a recent paper, which evaluated the role of V/P SPECT in patients with COPD, it was shown that V/P SPECT correlated significantly both to traditional lung function tests as well as the extent of emphysema as measured with HRCT (Jögi et al., 2011) . It was also shown that V/P SPECT could be used to characterize the severity of COPD. Pulmonary embolism and heart failure are common comorbidities with overlapping symptoms that www.intechopen.com complicate the manifestation of COPD. The prevalence of PE in patients hospitalized with exacerbation has been reported to be as high as 25% but is generally under-diagnosed (Mispelaere et al., 2002; Tillie-Leblond et al., 2006) . In patients with stable COPD, PE accounts for 10% of deaths (Schonhofer & Kohler, 1998) . The prevalence of heart failure among patients with stable COPD has been reported to be about 20% and even higher in patients with exacerbation (Rizkallah et al., 2009; Rutten et al., 2006) . The previous finding of the PIOPED study that V/P scintigraphy cannot be used to diagnose PE among patients with pathology of ventilation is an outdated belief (1990). Figure 7 shows extensive PE in a patient with COPD. This heavy smoker had a short history of progressive dyspnea. V/P SPECT showed uneven ventilation and perfusion with a pattern that is typical for COPD. Moreover, extensive perfusion defects were seen in areas with preserved ventilation. V/P quotient images could be used to quantify the extent of PE to approximately 70% of the lung parenchyma. Fig. 7 . Patient with severe COPD and chronic PE. Frontal slices; ventilation is very uneven in the whole lung. In addition, multiple perfusion defects are seen in ventilated areas. Mismatches are highlighted in V/P quotient images.
Heart failure
Left heart failure is a complex clinical syndrome that can result from any cardiac disorder that affects the ability of the left ventricle to function as a pump. When the left chamber is unable to meet the functional demands of the body, symptoms such as dyspnea and fatigue, as well as signs of pulmonary fluid retention appear. In patients with heart failure the risk of developing venous thromboembolic disease, including PE, is elevated (Anderson & Spencer, 2003) . As early as the 1960s, Friedman and Braunwald, West and others demonstrated that patients with mitral valve disease and left heart failure showed an inversion or www.intechopen.com "cephalization" of the normal dependent distribution of blood flow (Friedman & Braunwald, 1966; West et al., 1964) . The inverted distribution of blood flow to nondependent lung zones seen in heart failure has been correlated to elevated pulmonary venous pressure, interstitial oedema, alveolar space flooding and, when longstanding, perivascular fibrosis (Mohsenifar et al., 1989; Pistolesi et al., 1988) . Ventilation is not affected to the same degree as perfusion and mismatch in the dependent lung is therefore common. This mismatch, however, is not of a segmental character. V/P SPECT can therefore identify patients with congestive heart failure. In a study of 247 patients examined with V/P SPECT for suspected PE, we found that 15% of the patients had signs of heart failure, sometimes in combination with PE (Jögi et al., 2008) . Figure 8 shows a patient who suffered from increasing breathlessness. V/P SPECT was performed to exclude PE. V/P SPECT in supine position identified redistribution of ventilation and perfusion towards ventral regions ( Fig  8a) . Perfusion is more affected than ventilation and mismatch is therefore observed. This is, however, non-segmental and the diagnosis was therefore reported as heart failure and not PE. After 12 days of anticongestive treatment, the patient had improved clinically and the follow-up V/P SPECT (Fig 8b) showed complete normalization of both ventilation and perfusion. Fig. 8 . Patient with acute heart failure. A) In the supine patient, perfusion is redistributed to anterior parts of the lung. Ventilation is also affected but not to the same degree, which causes non-segmental perfusion defects. B). Follow up after 12 days of anticongestive treatment
Pneumonia
Pneumonia is an inflammatory condition of the lung parenchyma, especially affecting the alveoli. There are both infectious and non-infectious causes. The pneumonic regions of the lung become non-ventilated although the blood flow is often maintained to some extent. This can cause shunting and lead to hypoxemia. As the ventilation defect often exceeds the perfusion defect, reverse mismatch is a common finding (Carvalho & Lavender, 1989) . In a study by Li et al. (1994) reverse mismatch represented pneumonia in 81% of the cases. In severe cases both ventilation and perfusion are reduced or abolished and matched defects are then frequently found (Li et al., 1994) . Another sign of pneumonia that often has been described is the "stripe sign" (Sostman & Gottschalk, 1982 . The "stripe sign" refers to the observation of a stripe of a relatively well preserved perfusion adjacent to the pleural surface, by contrast with the more pronounced perfusion defects within the pneumonic lesion. This distinguishes pneumonia from the segmental perfusion defects found in PE. The enhanced performance of V/P SPECT compared to planar imaging has facilitated the detection of the stripe sign (Pace & Goris, 1998 ). Hampson as well as the ICOPER study illustrated that the risk of PE is increased in patients with pneumonia or other coexisting diseases (Elliott et al., 2000; Hampson, 1995) . In the ICOPER study, 17% of 2000 patients with confirmed PE had infiltrates on chest X-ray. Pneumonia has also been shown to be a common finding in patients with autopsy proven PE (Mandelli et al., 1997) .
Radiation exposure
The doses of 30 MBq and 120 MBq for ventilation and perfusion, respectively, allows excellent V/P SPECT quality at an effective radiation dose of 1.8 mSv (ICRP, 1998) . The absorbed dose to the breasts with V/P SPECT is 0.8 mGy (ICRP, 1998) . Estimation of exposure is relatively easy when short-lived radio-isotopes are used in nuclear medicine. In contrast, for X-ray technologies this is much more difficult because of a number of factors, such as differences in equipment and the size of the exposed fields. According to ICRP, the average effective dose for 4-16-detector MDCT is 5.4 mSv (Valentin, 2007) . Notably, this information was based on computed rather than measured dose data. Hurwitz et al. reported for a current adult PE protocol with 64-detector MDCT a measured effective dose of 19.9±1.38 mSv (Hurwitz et al., 2007) . These authors point out that the actual measured dose is about 50% higher than the computed dose. The absorbed dose to the breasts was 35-42 mGy. Absorbed radiation dose to the breast for a single-slice CT study was 20-50 mGy and 30-50% greater with a four-slice CT. In a very recent study, Hurwitz et al. (Hurwitz et al., 2009 ) studied radiation dose-saving protocols. Phantoms of women were exposed to MDCT protocols with automatic current modulation, lower tube voltage and bismuth shields over the chest. In the case of a medium sized female patient when automatic current modulation was applied at 140 kVp, breast doses were estimated at 62 mGy and this reduced to 33 mGy when bismuth shields were added. At 120 kVp the doses were 44 mGy without shields and 20 mGy with shields. Some limitations of the study were discussed. No phantom with significant subcutaneous fat was studied. The authors were not able to directly assess the effect of increased noise for the diagnosis of PE. Dose-saving protocols are promising.
Conclusions
The superiority of V/P SPECT over other imaging techniques in the diagnosis of PE has been well demonstrated. The examination is without contraindication and can be performed in 99% of patients with suspected PE. V/P SPECT makes it possible to quantify the extent of perfusion loss, so that PE treatment can be better adapted to the needs of individual patients. By using V/P SPECT, it is also possible to diagnose other cardiopulmonary conditions. Because of the very low radiation exposure, it is an ideal method for evaluating treatment and follow up. Low radiation doses are particularly important for women in the reproductive period and during pregnancy.
The above mentioned advantages of V/P SPECT for studying PE lead to the conclusion that it is the only suitable technique both for follow-up in patients with PE as well as for validation of treatment therapies. Moreover, it is an essential tool for research. Anderson, F.A., Jr., and Spencer, F.A. (2003) . Risk factors for venous thromboembolism.
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